BRPI0713252B8 - processo para a recuperação de fator de crescimento endotelial vascular (vegf) recombinante reenovelado - Google Patents

processo para a recuperação de fator de crescimento endotelial vascular (vegf) recombinante reenovelado

Info

Publication number
BRPI0713252B8
BRPI0713252B8 BRPI0713252A BRPI0713252A BRPI0713252B8 BR PI0713252 B8 BRPI0713252 B8 BR PI0713252B8 BR PI0713252 A BRPI0713252 A BR PI0713252A BR PI0713252 A BRPI0713252 A BR PI0713252A BR PI0713252 B8 BRPI0713252 B8 BR PI0713252B8
Authority
BR
Brazil
Prior art keywords
vegf
growth factor
vascular endothelial
endothelial growth
recovered recombinant
Prior art date
Application number
BRPI0713252A
Other languages
English (en)
Inventor
Sanchez Ailen
H Schmelzer Charles
Pizarro Shelly
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of BRPI0713252A2 publication Critical patent/BRPI0713252A2/pt
Publication of BRPI0713252B1 publication Critical patent/BRPI0713252B1/pt
Publication of BRPI0713252B8 publication Critical patent/BRPI0713252B8/pt
Publication of BRPI0713252C1 publication Critical patent/BRPI0713252C1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators

Abstract

processos para a recuperação de uma proteína recombinante reenovelada e método para purificar uma proteína recombinante. são fornecidos processos para a recuperação e purificação de proteínas recombinantes reenoveladas produzidas em células hospedeiras heteróloga, que inclui a etapa de reenovelamento da proteína em um tampão de ph elevado.
BRPI0713252A 2006-07-14 2007-07-13 processo para a recuperação de fator de crescimento endotelial vascular (vegf) recombinante reenovelado BRPI0713252C1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83083106P 2006-07-14 2006-07-14
US60/830,831 2006-07-14
PCT/US2007/073496 WO2008008975A2 (en) 2006-07-14 2007-07-13 Refolding of recombinant proteins

Publications (4)

Publication Number Publication Date
BRPI0713252A2 BRPI0713252A2 (pt) 2012-04-10
BRPI0713252B1 BRPI0713252B1 (pt) 2018-12-18
BRPI0713252B8 true BRPI0713252B8 (pt) 2019-04-09
BRPI0713252C1 BRPI0713252C1 (pt) 2021-05-25

Family

ID=38722613

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0713252A BRPI0713252C1 (pt) 2006-07-14 2007-07-13 processo para a recuperação de fator de crescimento endotelial vascular (vegf) recombinante reenovelado

Country Status (18)

Country Link
US (4) US20080125580A1 (pt)
EP (1) EP2041154B1 (pt)
JP (2) JP5566104B2 (pt)
KR (1) KR101520105B1 (pt)
CN (1) CN101506222B (pt)
AR (1) AR062069A1 (pt)
AU (1) AU2007272412B2 (pt)
BR (1) BRPI0713252C1 (pt)
CA (1) CA2656835C (pt)
IL (1) IL196004A (pt)
MX (1) MX2009000278A (pt)
MY (1) MY169472A (pt)
NZ (1) NZ573639A (pt)
RU (1) RU2439076C2 (pt)
SG (1) SG162834A1 (pt)
TW (1) TWI476207B (pt)
WO (1) WO2008008975A2 (pt)
ZA (1) ZA200900229B (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8329871B2 (en) * 2008-06-24 2012-12-11 Octapharma Ag Process of purifying coagulation factor VIII
AU2009284113B2 (en) 2008-08-21 2015-05-14 Octapharma Ag Recombinantly produced human factor VIII and IX
KR101063347B1 (ko) 2009-04-06 2011-09-07 인하대학교 산학협력단 이온성 액체를 이용한 이황화 결합을 포함하는 단백질의 재접힘 방법
US8067201B2 (en) * 2009-04-17 2011-11-29 Bristol-Myers Squibb Company Methods for protein refolding
CN102482321B (zh) 2009-06-22 2015-06-17 安姆根有限公司 使用化学控制的氧化还原态重折叠蛋白质
AU2010266093B2 (en) 2009-06-25 2013-06-27 Amgen Inc. Capture purification processes for proteins expressed in a non-mammalian system
KR20130140010A (ko) * 2010-10-20 2013-12-23 메디뮨 엘엘씨 봉입체의 가공처리 방법
WO2012147965A1 (ja) * 2011-04-28 2012-11-01 独立行政法人理化学研究所 生物材料を透明化する方法、及びその利用
CN103562702A (zh) 2011-05-20 2014-02-05 独立行政法人理化学研究所 生物材料用透明化试剂、及其利用
CN102443055B (zh) * 2011-10-26 2017-07-28 浙江海正药业股份有限公司 一种重组人肿瘤坏死因子相关凋亡诱导配体的纯化工艺
RU2492177C2 (ru) * 2011-12-15 2013-09-10 Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт генетики и селекции промышленных микроорганизмов" (ФГУП ГосНИИгенетика) СПОСОБ ВЫДЕЛЕНИЯ И ОЧИСТКИ РЕКОМБИНАНТНОГО ГОРМОНА РОСТА ЧЕЛОВЕКА, СЕКРЕТИРУЕМОГО ДРОЖЖАМИ Saccharomyces cerevisiae
CA2866753C (en) * 2012-03-27 2020-09-22 Genentech, Inc. Improved harvest operations for recombinant proteins
CN103588871B (zh) * 2012-08-16 2016-08-03 深圳新鹏生物工程有限公司 一种rhTRAIL菌体的分离纯化方法
ES2710314T3 (es) * 2012-12-20 2019-04-24 Medimmune Llc Métodos de producción de inmunoconjugados
US10065987B2 (en) * 2013-02-12 2018-09-04 Bristol-Myers Squibb Company High pH protein refolding methods
US10117823B2 (en) 2013-03-12 2018-11-06 Primal Therapies, Inc. Dental composition comprising chelator and base
US9982012B2 (en) 2013-03-29 2018-05-29 Dr. Reddy's Laboratories Limited Refolding of granulocyte colony stimulating factor
JP6433901B2 (ja) 2013-08-14 2018-12-05 国立研究開発法人理化学研究所 光透過性に優れた生物材料を調製するための組成物およびその利用
CN103694339B (zh) * 2013-12-04 2017-10-13 珠海联邦制药股份有限公司 一种甘精胰岛素前体的复性方法
KR101651330B1 (ko) * 2014-07-28 2016-08-25 가톨릭대학교 산학협력단 세포투과성이 우수한 ｔａｔ－ａ２０ 융합단백질의 제조방법 및 이의 용도
WO2016081288A1 (en) * 2014-11-18 2016-05-26 Merck Sharp & Dohme Corp. Process for refolding recombinant chymotrypsin
EP3221448B1 (en) 2014-11-18 2021-01-06 Merck Sharp & Dohme Corp. Process for producing recombinant trypsin
AU2015371341B2 (en) 2014-12-22 2021-05-20 Ucb Biopharma Sprl Method of protein manufacture
CA2969574A1 (en) * 2014-12-23 2016-06-30 Armo Biosciences, Inc. Methods of improving yield in recombinant protein production
DK3337820T3 (da) * 2015-08-17 2021-01-18 Lupin Ltd Forbedret fremgangsmåde til genfoldning af fragmenter af antistoffer
CN106008702B (zh) * 2016-07-22 2019-11-26 江苏江山聚源生物技术有限公司 一种规模化分离纯化重组人源胶原蛋白的方法
WO2018211529A1 (en) 2017-05-19 2018-11-22 Council Of Scientific & Industrial Research A method for producing refolded recombinant humanized ranibizumab
JP2022529811A (ja) * 2019-04-24 2022-06-24 タンベックス バイオファーマ ユーエスエー，インコーポレイティド 顆粒球コロニー刺激因子を調製するためのプロセス
KR20230066318A (ko) * 2020-06-26 2023-05-15 트레포일 테라퓨틱스, 인크. 재조합 변형된 섬유모세포 성장 인자 및 이의 치료적 용도
CN111848774B (zh) * 2020-08-05 2022-05-10 武汉海特生物制药股份有限公司 一种美曲普汀的制备方法
WO2023017540A1 (en) * 2021-08-11 2023-02-16 Tata Institute For Genetics And Society Methods for refolding a solubilized recombinant protein and implementation thereof

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4169950A (en) 1977-12-08 1979-10-02 Research Organics Amino-hydroxy-alkyl sulfonic acid zwitterions
US4565785A (en) * 1978-06-08 1986-01-21 The President And Fellows Of Harvard College Recombinant DNA molecule
EP0104771B1 (en) 1982-09-02 1990-05-23 Nellcor Incorporated Pulse oximeter monitor
US4673641A (en) * 1982-12-16 1987-06-16 Molecular Genetics Research And Development Limited Partnership Co-aggregate purification of proteins
US4512922A (en) * 1982-12-22 1985-04-23 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4511502A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4511503A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4490473A (en) * 1983-03-28 1984-12-25 Panab Labeled antibodies and methods
US4710473A (en) 1983-08-10 1987-12-01 Amgen, Inc. DNA plasmids
US4795706A (en) * 1985-01-31 1989-01-03 Eli Lilly And Company Novel expression control sequences
ES8800957A1 (es) * 1985-02-22 1987-12-01 Monsanto Co Un metodo para la solubilizacion y renaturalizacion de proteina somatotropina
US4652630A (en) 1985-02-22 1987-03-24 Monsanto Company Method of somatotropin naturation
DE3537708A1 (de) 1985-10-23 1987-04-23 Boehringer Mannheim Gmbh Verfahren zur aktivierung von t-pa nach expression in prokaryonten
US5453363A (en) * 1985-10-23 1995-09-26 Boehringer Mannheim Gmbh Process for the activation of t-PA or Ing after genetic expression in prokaryotes
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
US4929700A (en) * 1987-04-16 1990-05-29 Cetus Corporation Production of purified, biologically active, bacterially produced recombinant human CSF-1
DE3835350A1 (de) 1988-10-17 1990-04-19 Boehringer Mannheim Gmbh Aktivierung von gentechnologisch hergestellten, in prokaryonten exprimierten antikoerpern
US5064943A (en) * 1988-12-16 1991-11-12 American Cyanamid Company Method for solubilization and naturation of somatotropin
US5332671A (en) 1989-05-12 1994-07-26 Genetech, Inc. Production of vascular endothelial cell growth factor and DNA encoding same
US5194596A (en) 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
DE4037196A1 (de) 1990-11-22 1992-05-27 Boehringer Mannheim Gmbh Verfahren zur reaktivierung von denaturiertem protein
US5322699A (en) * 1991-02-04 1994-06-21 The Rockefeller University Leukocyte-derived CR3 modulator, integrin modulating factor-1 (IMF-1)
US5288931A (en) * 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
US5331095A (en) 1993-04-12 1994-07-19 Scios Nova Inc. Process for purification of basic fibroblast growth factor
JP4098372B2 (ja) 1993-07-28 2008-06-11 三菱化学株式会社 ヘパリン結合性増殖因子の生産方法
US5663304A (en) * 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
US5464815A (en) 1993-09-08 1995-11-07 Genentech, Inc. Inhibition of heparin-binding
DE69434538T2 (de) 1994-03-08 2006-08-10 Human Genome Sciences, Inc. Vaskulärer endothelialer Wachstumsfaktor 2
FR2729972B1 (fr) 1995-01-31 1997-04-18 Sanofi Sa Procede d'extraction de proteines periplasmiques de microorganismes procaryotes en presence d'arginine
SE9504019D0 (sv) 1995-11-13 1995-11-13 Pharmacia Ab Method for production of proteins
US6750044B1 (en) 1996-10-17 2004-06-15 Genentech, Inc. Variants of vascular endothelial cell growth factor having antagonistic properties, nucleic acids encoding the same and host cells comprising those nucleic acids
US6632425B1 (en) 1997-03-20 2003-10-14 Human Genome Sciences, Inc. Chemokine compositions
DE19735711C2 (de) * 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
US6653098B1 (en) * 1998-02-23 2003-11-25 G. D. Searle & Co. Method of producing mouse and human endostatin
WO1999050302A1 (en) 1998-03-31 1999-10-07 Tonghua Gantech Biotechnology Ltd. Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production
JP2002517406A (ja) 1998-06-01 2002-06-18 ジェネンテック・インコーポレーテッド イオン交換クロマトグラフィーの使用による、凝集体からのタンパク質モノマーの分離
PT1124941E (pt) 1998-10-28 2004-02-27 Genentech Inc Processo para recuperar polipeptidos heterologos a partir de celulas bacterianas
US6783953B1 (en) 1998-12-22 2004-08-31 Janssen Pharmaceutica N.V. Vascular endothelial growth factor-X
EP1183357A2 (en) 1999-05-20 2002-03-06 Scios Inc. Vascular endothelial growth factor dimers
US6206768B1 (en) * 1999-07-29 2001-03-27 Chartered Semiconductor Manufacturing, Ltd. Adjustable and extended guide rings
PT1255769E (pt) * 2000-01-25 2007-07-23 Oklahoma Med Res Found Procedimento universal para o re-enrolamento de proteínas recombinantes.
AUPQ568100A0 (en) 2000-02-16 2000-03-09 Amrad Operations Pty. Limited A method for producing recombinant molecules
EP1273655A4 (en) * 2000-03-30 2004-08-04 Takeda Chemical Industries Ltd METHOD FOR PRODUCING A RECOMBINANT PROTEIN
EP1284987B1 (en) 2000-05-16 2007-07-18 Bolder Biotechnology, Inc. Methods for refolding proteins containing free cysteine residues
PT1314437E (pt) * 2000-08-11 2014-08-29 Chugai Pharmaceutical Co Ltd Preparações estabilizadas contendo anticorpo
DE10054059A1 (de) 2000-10-31 2002-05-08 Max Delbrueck Centrum Verfahren zur Ermittlung von Faltungsbedingungen für rekombinante Proteine
US20040116663A1 (en) 2001-01-16 2004-06-17 Soren Buus Method for refolding of proteins
US7611711B2 (en) 2001-01-17 2009-11-03 Vegenics Limited VEGFR-3 inhibitor materials and methods
SK10472003A3 (sk) 2001-02-23 2004-03-02 Immunex Corporation Zvýšený výťažok aktívnych proteínov
US7323553B2 (en) * 2002-04-26 2008-01-29 Genentech, Inc. Non-affinity purification of proteins
CN1207307C (zh) * 2002-11-21 2005-06-22 李越希 重组人巨细胞病毒融合蛋白及其制备方法、应用
ZA200504990B (en) 2003-01-09 2006-08-30 Genentech Inc Purification of polypeptides
EP1449848A1 (en) 2003-02-20 2004-08-25 GBF German Research Centre for Biotechnology Method for the production of cystine-knot proteins
CN1473932A (zh) * 2003-06-30 2004-02-11 中山大学 一种重组石斑鱼腺苷酸环化酶激活多肽基因及其表达***、表达产物、生产方法和应用
KR20060135648A (ko) * 2003-12-10 2006-12-29 일라이 릴리 앤드 캄파니 섬유모세포 성장인자 21의 뮤테인
JP2007535911A (ja) 2003-12-30 2007-12-13 バハラ バイオテック インターナショナル リミテッド 組換えタンパク質の製造及び精製方法
US8084032B2 (en) * 2004-01-21 2011-12-27 Ajinomoto Co., Inc. Purification method which prevents denaturation of an antibody
DE102004015965A1 (de) * 2004-04-01 2005-10-20 Aventis Pharma Gmbh Verfahren zur Gewinnung von Insulinen durch verbesserte Luftbegasung der Faltung
JP4940136B2 (ja) * 2004-06-28 2012-05-30 イエダ リサーチ アンド ディベロップメント カンパニー リミテッド キメラタンパク質およびその使用
NZ555353A (en) * 2004-11-22 2009-12-24 Anaphore Inc TNF antagonists
DE602006003108D1 (de) * 2005-03-03 2008-11-27 Ajinomoto Kk Methode zur Verbesserung der Ausbeute bei der Proteinreinigung mittels Gelfiltrationschromatographie und Arginin
CA2633554C (en) 2005-12-22 2012-11-13 Genetech, Inc. Recombinant production of heparin binding proteins

Also Published As

Publication number Publication date
BRPI0713252C1 (pt) 2021-05-25
AU2007272412A1 (en) 2008-01-17
RU2009105080A (ru) 2010-08-27
CA2656835A1 (en) 2008-01-17
JP6120356B2 (ja) 2017-04-26
JP2009543882A (ja) 2009-12-10
IL196004A (en) 2014-06-30
EP2041154B1 (en) 2018-12-12
RU2439076C2 (ru) 2012-01-10
BRPI0713252B1 (pt) 2018-12-18
AR062069A1 (es) 2008-10-15
SG162834A1 (en) 2010-07-29
TW200813093A (en) 2008-03-16
JP5566104B2 (ja) 2014-08-06
MX2009000278A (es) 2009-01-26
KR101520105B1 (ko) 2015-05-21
ZA200900229B (en) 2010-04-28
JP2013121362A (ja) 2013-06-20
US9200030B2 (en) 2015-12-01
WO2008008975A3 (en) 2008-04-10
WO2008008975A2 (en) 2008-01-17
CN101506222A (zh) 2009-08-12
NZ573639A (en) 2012-03-30
IL196004A0 (en) 2011-08-01
EP2041154A2 (en) 2009-04-01
AU2007272412B2 (en) 2013-11-07
US20080125580A1 (en) 2008-05-29
TWI476207B (zh) 2015-03-11
CN101506222B (zh) 2013-10-02
US20110294990A1 (en) 2011-12-01
US20160137690A1 (en) 2016-05-19
US20130123474A1 (en) 2013-05-16
KR20090039772A (ko) 2009-04-22
MY169472A (en) 2019-04-12
WO2008008975A8 (en) 2008-10-16
BRPI0713252A2 (pt) 2012-04-10
CA2656835C (en) 2017-12-19
US9994612B2 (en) 2018-06-12

Similar Documents

Publication Publication Date Title
BRPI0713252B8 (pt) processo para a recuperação de fator de crescimento endotelial vascular (vegf) recombinante reenovelado
DK1422237T3 (da) Fremgangsmåder til rekombinant frembringelse af antifusogene peptider
DK1874932T3 (da) Produktion af rekombinante proteiner ved autoproteolytisk spaltning af et fusionsprotein
BRPI0611600B8 (pt) método para purificação de uma proteína tendo uma região fc a partir de um líquido fonte compreendendo a proteína e uma ou mais impurezas, e kit
ES2353814T3 (es) Proteinas n-glicosiladas recombinantes de celulas procariotas.
CO5601037A2 (es) Anticuerpos anti-a beta y sus usos
EA200970231A1 (ru) СПОСОБ ОЧИСТКИ Fc-СОДЕРЖАЩИХ БЕЛКОВ
DE602006014126D1 (de) Zusammensetzungen und verfahren zur trennung von fusionsproteinen
DE602005009856D1 (de) Verfahren zur reinigung von fsh
WO2007130535A3 (en) Novel protein fusion/tag technology
DE602008004747D1 (de) Verfahren zur aufreinigung hydrophober proteine
ATE525466T1 (de) Verfahren und testkit zur trennung, aufreinigung und wiedergewinnung von lang- und kurzkettigen nukleinsäuren
ATE417056T1 (de) Verfahren zur proteinreinigung
MY143274A (en) Recombinant production of heparin binding proteins
ATE442445T1 (de) Rhamnose-induzierbares expressionssystem
DK1400589T3 (da) Fremgangsmåde til påvisning af prokaryotisk DNA
TW200517398A (en) Method for recombinant protein purification, modification and immobilization
ATE486943T1 (de) Schnelles screening-verfahren translationaler fusionspartner zur produktion rekombinanter proteine sowie durch screening damit erhaltene translationale fusionspartner
DE602007012053D1 (de) Affinitätspolypeptid zur reinigung von rekombinanten proteinen
EA200702009A1 (ru) Усовершенствованный способ экспрессирующего клонирования в клетке-хозяине
TW200724687A (en) Immobilized proteins based on oil body
ATE339523T1 (de) Verfahren zur herstellung von rekombinanten nukleinsäuremolekülen
BRPI0214903A2 (pt) ácido nucléico isolado codificador de uma molécula precursora de trombina bovina recombinante, polinucleotídeo codificador de um polipeptídeo, molécula precursora, vetor, célula hospedeira, processo para a purificação de trombina ativada, e, método de produção de uma proteína ativada
WO2011015379A8 (en) Human hcv-interacting proteins and methods of use
ATE509107T1 (de) Aufreinigung von fc-tact-fusionsproteinen unter verwendung der ölkörper-technik

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 18/12/2018, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 18/12/2018, OBSERVADAS AS CONDICOES LEGAIS. (CO) REFERENTE A RPI 2502 DE 18/12/2018,QUANTO AO ENDERECO DO DEPOSITANTE.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/07/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF